Form 4: Alignment Healthcare CFO Robert Freeman Reports Stock Transactions
SEC Form 4 Filing
Robert Freeman, CFO of Alignment Healthcare, reports acquisition of shares through restricted stock units and sale of shares to cover tax obligations.
Summary
- Robert Freeman, the Chief Financial Officer of Alignment Healthcare, reported transactions involving the company's common stock.
- On March 13, 2024, Freeman acquired 200,710 shares of common stock at $0.00.
- These shares were acquired through restricted stock units, a discretionary award from the Board of Directors, and in lieu of cash settlement for the 2023 annual incentive award.
- On March 15, 2024, Freeman sold 11,858 shares at an average price of $4.8911 to cover tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Freeman directly owns 898,228 shares and indirectly owns 519,429 shares through FCO Holdings LLC.
- The indirect ownership is held through FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The acquisition of shares is a positive sign, but the sale, even for tax purposes, tempers the overall sentiment.
Positives
- The acquisition of shares by the CFO demonstrates confidence in the company's future.
- The grant of restricted stock units and shares in lieu of cash incentivizes the CFO to perform well.
Negatives
- The sale of shares, although for tax obligations, could be perceived negatively by some investors.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors monitor these filings to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders' perception of the stock.
- The sale of shares to cover tax obligations does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/13/2024 | Acquisition of 200,710 shares of common stock. |
| 03/15/2024 | Sale of 11,858 shares of common stock to cover tax obligations. |
| 03/15/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.